Page last updated: 2024-08-23

pimonidazole and Prostatic Neoplasms

pimonidazole has been researched along with Prostatic Neoplasms in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (50.00)29.6817
2010's3 (37.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Gaffney, J; Hompland, T; Leech, M; Leijenaar, RTH; Lyng, H; Marignol, L1
Axcrona, K; Frikstad, KM; Hole, KH; Julin, CH; Lie, AK; Lyng, H; Ragnum, HB; Seierstad, T; Vlatkovic, L1
Ackerstaff, E; Carlin, S; Cho, H; Humm, JL; Koutcher, JA; Ling, CC; Lupu, ME; O'Donoghue, J; Rizwan, A; Wang, Y; Zanzonico, PB1
Chen, FH; Chiang, CS; Fu, SY; Hong, JH; Jung, SM; Lee, CC; Tsai, CS; Wang, CC; Wen, CJ1
Hagtvet, E; Olsen, DR; Røe, K1
Campa, J; Carlin, S; Humm, JL; Larson, SM; Ling, CC; Pugachev, A; Ruan, S1
Bentzen, SM; Carnell, DM; Daley, FM; Hoskin, PJ; Saunders, MI; Smith, RE1
Bentzen, SM; Carnell, DM; Collins, DJ; d'Arcy, JA; Daley, FM; Hoskin, PJ; Padhani, AP; Saunders, MI; Smith, RE; Stirling, JJ; Taylor, NJ1

Other Studies

8 other study(ies) available for pimonidazole and Prostatic Neoplasms

ArticleYear
Exploring Hypoxia in Prostate Cancer With T2-weighted Magnetic Resonance Imaging Radiomics and Pimonidazole Scoring.
    Anticancer research, 2023, Volume: 43, Issue:1

    Topics: Humans; Magnetic Resonance Imaging; Male; Nitroimidazoles; Prostate; Prostatic Neoplasms; Retrospective Studies

2023
The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer.
    British journal of cancer, 2015, Jan-20, Volume: 112, Issue:2

    Topics: Cell Hypoxia; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Nitroimidazoles; Proportional Hazards Models; Prostatic Neoplasms; Staining and Labeling; Tissue Distribution; Transcriptome

2015
Noninvasive multimodality imaging of the tumor microenvironment: registered dynamic magnetic resonance imaging and positron emission tomography studies of a preclinical tumor model of tumor hypoxia.
    Neoplasia (New York, N.Y.), 2009, Volume: 11, Issue:3

    Topics: Animals; Autoradiography; Cell Hypoxia; Disease Models, Animal; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Misonidazole; Nitroimidazoles; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Rats

2009
Vasculatures in tumors growing from preirradiated tissues: formed by vasculogenesis and resistant to radiation and antiangiogenic therapy.
    International journal of radiation oncology, biology, physics, 2011, Aug-01, Volume: 80, Issue:5

    Topics: Angiogenesis Inhibitors; Animals; Bone Marrow Transplantation; Cell Aggregation; Cell Hypoxia; Cell Line, Tumor; Coloring Agents; Drug Resistance, Neoplasm; Endothelial Cells; Green Fluorescent Proteins; Indoles; Macrophages; Male; Mice; Mice, Inbred C57BL; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Neovascularization, Pathologic; Nitroimidazoles; Prostatic Neoplasms; Pyrroles; Radiation Dosage; Radiation Tolerance; Radiation-Sensitizing Agents; Salvage Therapy; Sunitinib; Tumor Burden; Tumor Microenvironment; Xenograft Model Antitumor Assays

2011
Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts.
    Radiation oncology (London, England), 2011, Oct-07, Volume: 6

    Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Combined Modality Therapy; Contrast Media; Doxorubicin; Humans; Hypoxia; Immunohistochemistry; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Models, Theoretical; Neoplasm Transplantation; Nitroimidazoles; Prostatic Neoplasms; Treatment Outcome

2011
Dependence of FDG uptake on tumor microenvironment.
    International journal of radiation oncology, biology, physics, 2005, Jun-01, Volume: 62, Issue:2

    Topics: Animals; Autoradiography; Benzimidazoles; Bromodeoxyuridine; Cell Hypoxia; Cell Proliferation; Coloring Agents; Fluorodeoxyglucose F18; Glucose; Male; Mice; Mice, Nude; Neoplasms; Nitroimidazoles; Prostatic Neoplasms; Radiopharmaceuticals

2005
An immunohistochemical assessment of hypoxia in prostate carcinoma using pimonidazole: implications for radioresistance.
    International journal of radiation oncology, biology, physics, 2006, May-01, Volume: 65, Issue:1

    Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Cell Hypoxia; Humans; Immunohistochemistry; Male; Middle Aged; Nitroimidazoles; Prostatic Neoplasms; Radiation-Sensitizing Agents

2006
Hypoxia in prostate cancer: correlation of BOLD-MRI with pimonidazole immunohistochemistry-initial observations.
    International journal of radiation oncology, biology, physics, 2007, Jul-15, Volume: 68, Issue:4

    Topics: Aged; Cell Hypoxia; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nitroimidazoles; Oxygen; Prostatectomy; Prostatic Neoplasms; Radiation-Sensitizing Agents; Staining and Labeling

2007